Showing results (251-260 of 336) with videos related to
Sort By:
Pageof 34
Cancer Letters|May 6, 2023
Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myelomaHongmei Luo, Yu Feng, Fangfang Wang, et al.Scientific Reports|October 27, 2015
SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AMLShuang Ma, Ling-Ling Yang, Ting Niu, et al.Bioactive Materials|January 16, 2026
Microenvironment-mediated stem cell fate in periodontal tissue remodeling and repairJin-Xuan Zheng, Han Yin, Guang-Zhao Tian, et al.Journal of Gastrointestinal Oncology|May 22, 2026
Impact of preoperative body weight on short-term and long-term prognosis after pancreatic resection for pancreatic ductal adenocarcinoma: a multicenter studyJudong Li, Ting Niu, Ligang Shi, et al.The Lancet Regional Health. Western Pacific|August 23, 2024
Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trialMing-Ci Cai, Shu Cheng, Hong-Mei Jing, et al.JCI Insight|August 30, 2022
ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5Yan Yang, Yuhan Gao, Jingcao Huang, et al.International Journal of Hematology|July 4, 2012
A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopeniaShujie Wang, Renchi Yang, Ping Zou, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 22, 2022
Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone DiseaseYushan Cui, Fangfang Wang, Danfeng Zhang, et al.Current Medical Science|June 6, 2024
Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 AxisYing Chen, Bi-Xia Li, Ting-Ting Niu, et al.Oncotarget|January 18, 2018
A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) modelsNannan Zhang, Guo Zhang, Ning Liu, et al.Pageof 34